The treatment, Paxlovid, is the second antiviral pill to show effectiveness in treating Covid, and works differently from the first.
https://siii-clinical.com/wp-content/uploads/2021/09/Untitled-1.png00https://siii-clinical.com/wp-content/uploads/2021/09/Untitled-1.png2021-11-16 20:02:492021-11-16 20:02:49Pfizer Asks F.D.A. to Authorize Covid Pill For Unvaccinated People
From research laboratories to clinical settings, SIII integrates the technologies, resources, and expertise our customers need to rise to the next opportunity. SIII is dedicated to exploring and researching the processes and scientific mechanisms underlying the world we live in.